Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US13207910Application Date: 2011-08-11
-
Publication No.: US08697704B2Publication Date: 2014-04-15
- Inventor: Yao-Ling Qiu , Xiaowen Peng , Ce Wang , Yat Sun Or
- Applicant: Yao-Ling Qiu , Xiaowen Peng , Ce Wang , Yat Sun Or
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Roy P. Issac, Esq.; Carolyn S. Elmore, Esq.
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D413/14 ; C07D498/08
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20120039848A1 HEPATITIS C VIRUS INHIBITORS Public/Granted day:2012-02-16
Information query
